Advanced search
Publication Cover
Expert Review of Hematology Volume 10, 2017 - Issue 3
Submit an article Journal homepage
536
Views
10
CrossRef citations to date
0
Altmetric
Perspective

When to treat patients with relapsed follicular lymphoma

Chan Yoon CheahDepartment of Haematology, Sir Charles Gairdner Hospital and Pathwest Laboratory Medicine, Nedlands, WA, Australia;Medical School, University of Western Australia, Crawley, WA, AustraliaView further author information
&
John F SeymourDepartment of Haematology, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Parkville, VIC, Australia;Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, AustraliaCorrespondence[email protected]
View further author information
Pages 187-191 | Received 26 Sep 2016, Accepted 02 Feb 2017, Published online: 15 Feb 2017

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jiajia Liu, Douglas Stewart, Amelie Fontaine, Anthea Peters, Isabelle Fleury, Luigina Mollica, Anca Prica, Rena Buckstein, Laurie Sehn, Aixiang Jiang, John Kuruvilla & Diego Villa. (2020) Characteristics and outcomes of patients with relapsed follicular lymphoma following retreatment with second-line rituximab-containing chemotherapy. Leukemia & Lymphoma 61:10, pages 2492-2496.
Read now
Marc Sorigue, Edurne Sarrate, Josep-Maria Ribera & Juan-Manuel Sancho. (2018) The case for lymphoma-specific survival. Expert Review of Hematology 11:4, pages 263-264.
Read now

Articles from other publishers (8)

Lale Kostakoglu, Maurizio Martelli, Laurie H. Sehn, Andrew Davies, Marek Trněný, Michael Herold, Umberto Vitolo, Wolfgang Hiddemann, Judith Trotman, Andrea Knapp, Federico Mattiello, Tina G. Nielsen, Deniz Sahin, Gila Sellam, Carol Ward & Anas Younes. (2023) A comparison of the prognostic performance of the Lugano 2014 and RECIL 2017 response criteria in patients with NHL from the phase III GOYA and GALLIUM trials. eJHaem 4:4, pages 1042-1051.
Crossref
Anas Younes, John M. Burke, Catherine Diefenbach, Silvia Ferrari, Cyrus Khan, Jeff P. Sharman, Monica Tani, Chaitra Ujjani, Umberto Vitolo, Sam Yuen, Aparna Raval, Mahesh Shivhare, Tina G. Nielsen, Gila Sellam & Michael Gilbertson. (2022) Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma. Blood Advances 6:20, pages 5659-5667.
Crossref
Tarec Christoffer El‐Galaly, Andreas Kiesbye Øvlisen & Chan Yoon Cheah. (2021) Routine imaging for disease surveillance in follicular lymphoma—To comfort the patients or their doctors?. Cancer 127:18, pages 3298-3301.
Crossref
Arimelek Cortés-Hernández, Evelyn Katy Alvarez-Salazar & Gloria Soldevila. 2021. Cancer Cell Signaling. Cancer Cell Signaling 219 244 .
Guilherme Fleury Perini, Thais Fischer, Rafael Dezen Gaiolla, Talita Bueno Rocha, Marcelo Bellesso, Larissa Lane Cardoso Teixeira, Marcia Torresan Delamain, Adriana Alves de Souza Scheliga, Glaciano Nogueira Ribeiro, Jorge Vaz Neto, Otávio Cesar Carvalho Guimaraes Baiocchi, André Neder Ramires Abdo, Celso Arrais-Rodrigues, Laura M. Fogliatto, Ricardo de Sá Bigni, Rony Schaffel, Irene Biasoli, Juliana Pereira, Samir Kanaan Nabhan, Cármino Antônio de Souza & Carlos Sérgio Chiattone. (2020) How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation. Hematology, Transfusion and Cell Therapy 42:2, pages 103-110.
Crossref
Evgeniya V. Kharchenko & John W. Sweetenham. (2019) Advances in relapsed/refractory follicular lymphoma therapeutics. ADVANCES IN CELL AND GENE THERAPY 3:1.
Crossref
Stephen Opat, Michael Dickinson, Chan Yoon Cheah, Constantine Tam, Joy Boulos, Alison Nicole Thorburn & Judith Trotman. (2019) Management of patients with follicular lymphoma treated first line with obinutuzumab. Asia-Pacific Journal of Clinical Oncology 15:S3, pages 3-11.
Crossref
Chan Yoon Cheah & Nathan H. Fowler. (2018) Novel agents for relapsed and refractory follicular lymphoma. Best Practice & Research Clinical Haematology 31:1, pages 41-48.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.